Celgene’s Thalomid “Approvable” Again For Multiple Myeloma
FDA’s second approvable letter calls for labeling changes specific to an indication for newly diagnosed multiple myeloma.
FDA’s second approvable letter calls for labeling changes specific to an indication for newly diagnosed multiple myeloma.